Copyright Reports & Markets. All rights reserved.

Global Pediatric Drugs and Vaccines Sales Market Report 2021

Buy now

1 Pediatric Drugs and Vaccines Market Overview

  • 1.1 Pediatric Drugs and Vaccines Product Scope
  • 1.2 Pediatric Drugs and Vaccines Segment by Type
    • 1.2.1 Global Pediatric Drugs and Vaccines Sales by Type (2016 & 2021 & 2027)
    • 1.2.2 Diphtheria
    • 1.2.3 Influenza
    • 1.2.4 Hepatitis
    • 1.2.5 Pneumococcal Diseases
    • 1.2.6 Meningococcal Diseases
    • 1.2.7 Mumps
    • 1.2.8 Others
  • 1.3 Pediatric Drugs and Vaccines Segment by Application
    • 1.3.1 Global Pediatric Drugs and Vaccines Sales Comparison by Application (2016 & 2021 & 2027)
    • 1.3.2 Newborn
    • 1.3.3 Infant
    • 1.3.4 Child
  • 1.4 Pediatric Drugs and Vaccines Market Estimates and Forecasts (2016-2027)
    • 1.4.1 Global Pediatric Drugs and Vaccines Market Size in Value Growth Rate (2016-2027)
    • 1.4.2 Global Pediatric Drugs and Vaccines Market Size in Volume Growth Rate (2016-2027)
    • 1.4.3 Global Pediatric Drugs and Vaccines Price Trends (2016-2027)

2 Pediatric Drugs and Vaccines Estimates and Forecasts by Region

  • 2.1 Global Pediatric Drugs and Vaccines Market Size by Region: 2016 VS 2021 VS 2027
  • 2.2 Global Pediatric Drugs and Vaccines Retrospective Market Scenario by Region (2016-2021)
    • 2.2.1 Global Pediatric Drugs and Vaccines Sales Market Share by Region (2016-2021)
    • 2.2.2 Global Pediatric Drugs and Vaccines Revenue Market Share by Region (2016-2021)
  • 2.3 Global Pediatric Drugs and Vaccines Market Estimates and Forecasts by Region (2022-2027)
    • 2.3.1 Global Pediatric Drugs and Vaccines Sales Estimates and Forecasts by Region (2022-2027)
    • 2.3.2 Global Pediatric Drugs and Vaccines Revenue Forecast by Region (2022-2027)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America Pediatric Drugs and Vaccines Estimates and Projections (2016-2027)
    • 2.4.2 Europe Pediatric Drugs and Vaccines Estimates and Projections (2016-2027)
    • 2.4.3 China Pediatric Drugs and Vaccines Estimates and Projections (2016-2027)
    • 2.4.4 Japan Pediatric Drugs and Vaccines Estimates and Projections (2016-2027)
    • 2.4.5 Southeast Asia Pediatric Drugs and Vaccines Estimates and Projections (2016-2027)
    • 2.4.6 India Pediatric Drugs and Vaccines Estimates and Projections (2016-2027)

3 Global Pediatric Drugs and Vaccines Competition Landscape by Players

  • 3.1 Global Top Pediatric Drugs and Vaccines Players by Sales (2016-2021)
  • 3.2 Global Top Pediatric Drugs and Vaccines Players by Revenue (2016-2021)
  • 3.3 Global Pediatric Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pediatric Drugs and Vaccines as of 2020)
  • 3.4 Global Pediatric Drugs and Vaccines Average Price by Company (2016-2021)
  • 3.5 Manufacturers Pediatric Drugs and Vaccines Manufacturing Sites, Area Served, Product Type
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Pediatric Drugs and Vaccines Market Size by Type

  • 4.1 Global Pediatric Drugs and Vaccines Historic Market Review by Type (2016-2021)
    • 4.1.1 Global Pediatric Drugs and Vaccines Sales Market Share by Type (2016-2021)
    • 4.1.2 Global Pediatric Drugs and Vaccines Revenue Market Share by Type (2016-2021)
    • 4.1.3 Global Pediatric Drugs and Vaccines Price by Type (2016-2021)
  • 4.2 Global Pediatric Drugs and Vaccines Market Estimates and Forecasts by Type (2022-2027)
    • 4.2.1 Global Pediatric Drugs and Vaccines Sales Forecast by Type (2022-2027)
    • 4.2.2 Global Pediatric Drugs and Vaccines Revenue Forecast by Type (2022-2027)
    • 4.2.3 Global Pediatric Drugs and Vaccines Price Forecast by Type (2022-2027)

5 Global Pediatric Drugs and Vaccines Market Size by Application

  • 5.1 Global Pediatric Drugs and Vaccines Historic Market Review by Application (2016-2021)
    • 5.1.1 Global Pediatric Drugs and Vaccines Sales Market Share by Application (2016-2021)
    • 5.1.2 Global Pediatric Drugs and Vaccines Revenue Market Share by Application (2016-2021)
    • 5.1.3 Global Pediatric Drugs and Vaccines Price by Application (2016-2021)
  • 5.2 Global Pediatric Drugs and Vaccines Market Estimates and Forecasts by Application (2022-2027)
    • 5.2.1 Global Pediatric Drugs and Vaccines Sales Forecast by Application (2022-2027)
    • 5.2.2 Global Pediatric Drugs and Vaccines Revenue Forecast by Application (2022-2027)
    • 5.2.3 Global Pediatric Drugs and Vaccines Price Forecast by Application (2022-2027)

6 North America Pediatric Drugs and Vaccines Market Facts & Figures

  • 6.1 North America Pediatric Drugs and Vaccines Sales by Company
    • 6.1.1 North America Pediatric Drugs and Vaccines Sales by Company (2016-2021)
    • 6.1.2 North America Pediatric Drugs and Vaccines Revenue by Company (2016-2021)
  • 6.2 North America Pediatric Drugs and Vaccines Sales Breakdown by Type
    • 6.2.1 North America Pediatric Drugs and Vaccines Sales Breakdown by Type (2016-2021)
    • 6.2.2 North America Pediatric Drugs and Vaccines Sales Breakdown by Type (2022-2027)
  • 6.3 North America Pediatric Drugs and Vaccines Sales Breakdown by Application
    • 6.3.1 North America Pediatric Drugs and Vaccines Sales Breakdown by Application (2016-2021)
    • 6.3.2 North America Pediatric Drugs and Vaccines Sales Breakdown by Application (2022-2027)

7 Europe Pediatric Drugs and Vaccines Market Facts & Figures

  • 7.1 Europe Pediatric Drugs and Vaccines Sales by Company
    • 7.1.1 Europe Pediatric Drugs and Vaccines Sales by Company (2016-2021)
    • 7.1.2 Europe Pediatric Drugs and Vaccines Revenue by Company (2016-2021)
  • 7.2 Europe Pediatric Drugs and Vaccines Sales Breakdown by Type
    • 7.2.1 Europe Pediatric Drugs and Vaccines Sales Breakdown by Type (2016-2021)
    • 7.2.2 Europe Pediatric Drugs and Vaccines Sales Breakdown by Type (2022-2027)
  • 7.3 Europe Pediatric Drugs and Vaccines Sales Breakdown by Application
    • 7.3.1 Europe 143 Sales Breakdown by Application (2016-2021)
    • 7.3.2 Europe 143 Sales Breakdown by Application (2022-2027)

8 China Pediatric Drugs and Vaccines Market Facts & Figures

  • 8.1 China Pediatric Drugs and Vaccines Sales by Company
    • 8.1.1 China Pediatric Drugs and Vaccines Sales by Company (2016-2021)
    • 8.1.2 China Pediatric Drugs and Vaccines Revenue by Company (2016-2021)
  • 8.2 China Pediatric Drugs and Vaccines Sales Breakdown by Type
    • 8.2.1 China Pediatric Drugs and Vaccines Sales Breakdown by Type (2016-2021)
    • 8.2.2 China Pediatric Drugs and Vaccines Sales Breakdown by Type (2022-2027)
  • 8.3 China Pediatric Drugs and Vaccines Sales Breakdown by Application
    • 8.3.1 China 163 Sales Breakdown by Application (2016-2021)
    • 8.3.2 China 163 Sales Breakdown by Application (2022-2027)

9 Japan Pediatric Drugs and Vaccines Market Facts & Figures

  • 9.1 Japan Pediatric Drugs and Vaccines Sales by Company
    • 9.1.1 Japan Pediatric Drugs and Vaccines Sales by Company (2016-2021)
    • 9.1.2 Japan Pediatric Drugs and Vaccines Revenue by Company (2016-2021)
  • 9.2 Japan Pediatric Drugs and Vaccines Sales Breakdown by Type
    • 9.2.1 Japan Pediatric Drugs and Vaccines Sales Breakdown by Type (2016-2021)
    • 9.2.2 Japan Pediatric Drugs and Vaccines Sales Breakdown by Type (2022-2027)
  • 9.3 Japan Pediatric Drugs and Vaccines Sales Breakdown by Application
    • 9.3.1 Japan Mar. Sales Breakdown by Application (2016-2021)
    • 9.3.2 Japan Mar. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Pediatric Drugs and Vaccines Market Facts & Figures

  • 10.1 Southeast Asia Pediatric Drugs and Vaccines Sales by Company
    • 10.1.1 Southeast Asia Pediatric Drugs and Vaccines Sales by Company (2016-2021)
    • 10.1.2 Southeast Asia Pediatric Drugs and Vaccines Revenue by Company (2016-2021)
  • 10.2 Southeast Asia Pediatric Drugs and Vaccines Sales Breakdown by Type
    • 10.2.1 Southeast Asia Pediatric Drugs and Vaccines Sales Breakdown by Type (2016-2021)
    • 10.2.2 Southeast Asia Pediatric Drugs and Vaccines Sales Breakdown by Type (2022-2027)
  • 10.3 Southeast Asia Pediatric Drugs and Vaccines Sales Breakdown by Application
    • 10.3.1 Southeast Asia Kg Sales Breakdown by Application (2016-2021)
    • 10.3.2 Southeast Asia Kg Sales Breakdown by Application (2022-2027)

11 India Pediatric Drugs and Vaccines Market Facts & Figures

  • 11.1 India Pediatric Drugs and Vaccines Sales by Company
    • 11.1.1 India Pediatric Drugs and Vaccines Sales by Company (2016-2021)
    • 11.1.2 India Pediatric Drugs and Vaccines Revenue by Company (2016-2021)
  • 11.2 India Pediatric Drugs and Vaccines Sales Breakdown by Type
    • 11.2.1 India Pediatric Drugs and Vaccines Sales Breakdown by Type (2016-2021)
    • 11.2.2 India Pediatric Drugs and Vaccines Sales Breakdown by Type (2022-2027)
  • 11.3 India Pediatric Drugs and Vaccines Sales Breakdown by Application
    • 11.3.1 India Pediatric Drugs and Vaccines Sales Breakdown by Application (2016-2021)
    • 11.3.2 India Pediatric Drugs and Vaccines Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Pediatric Drugs and Vaccines Business

  • 12.1 Merck & Co., Inc. (USA)
    • 12.1.1 Merck & Co., Inc. (USA) Corporation Information
    • 12.1.2 Merck & Co., Inc. (USA) Business Overview
    • 12.1.3 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
    • 12.1.4 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Products Offered
    • 12.1.5 Merck & Co., Inc. (USA) Recent Development
  • 12.2 Abbott Laboratories (USA)
    • 12.2.1 Abbott Laboratories (USA) Corporation Information
    • 12.2.2 Abbott Laboratories (USA) Business Overview
    • 12.2.3 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
    • 12.2.4 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Products Offered
    • 12.2.5 Abbott Laboratories (USA) Recent Development
  • 12.3 Amgen, Inc. (USA)
    • 12.3.1 Amgen, Inc. (USA) Corporation Information
    • 12.3.2 Amgen, Inc. (USA) Business Overview
    • 12.3.3 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
    • 12.3.4 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Products Offered
    • 12.3.5 Amgen, Inc. (USA) Recent Development
  • 12.4 Eli Lilly and Company (USA)
    • 12.4.1 Eli Lilly and Company (USA) Corporation Information
    • 12.4.2 Eli Lilly and Company (USA) Business Overview
    • 12.4.3 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
    • 12.4.4 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Products Offered
    • 12.4.5 Eli Lilly and Company (USA) Recent Development
  • 12.5 F. Hoffmann-La Roche Ltd (Switzerland)
    • 12.5.1 F. Hoffmann-La Roche Ltd (Switzerland) Corporation Information
    • 12.5.2 F. Hoffmann-La Roche Ltd (Switzerland) Business Overview
    • 12.5.3 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
    • 12.5.4 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Products Offered
    • 12.5.5 F. Hoffmann-La Roche Ltd (Switzerland) Recent Development
  • 12.6 Genentech, Inc. (USA)
    • 12.6.1 Genentech, Inc. (USA) Corporation Information
    • 12.6.2 Genentech, Inc. (USA) Business Overview
    • 12.6.3 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
    • 12.6.4 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Products Offered
    • 12.6.5 Genentech, Inc. (USA) Recent Development
  • 12.7 GlaxoSmithKline plc. (UK)
    • 12.7.1 GlaxoSmithKline plc. (UK) Corporation Information
    • 12.7.2 GlaxoSmithKline plc. (UK) Business Overview
    • 12.7.3 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
    • 12.7.4 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Products Offered
    • 12.7.5 GlaxoSmithKline plc. (UK) Recent Development
  • 12.8 Janssen Biologics B.V. (USA)
    • 12.8.1 Janssen Biologics B.V. (USA) Corporation Information
    • 12.8.2 Janssen Biologics B.V. (USA) Business Overview
    • 12.8.3 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
    • 12.8.4 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Products Offered
    • 12.8.5 Janssen Biologics B.V. (USA) Recent Development
  • 12.9 Actelion Pharmaceuticals
    • 12.9.1 Actelion Pharmaceuticals Corporation Information
    • 12.9.2 Actelion Pharmaceuticals Business Overview
    • 12.9.3 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
    • 12.9.4 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Products Offered
    • 12.9.5 Actelion Pharmaceuticals Recent Development
  • 12.10 AstraZeneca Plc. (UK)
    • 12.10.1 AstraZeneca Plc. (UK) Corporation Information
    • 12.10.2 AstraZeneca Plc. (UK) Business Overview
    • 12.10.3 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
    • 12.10.4 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Products Offered
    • 12.10.5 AstraZeneca Plc. (UK) Recent Development
  • 12.11 Boehringer Ingelheim GmbH (Germany)
    • 12.11.1 Boehringer Ingelheim GmbH (Germany) Corporation Information
    • 12.11.2 Boehringer Ingelheim GmbH (Germany) Business Overview
    • 12.11.3 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
    • 12.11.4 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Products Offered
    • 12.11.5 Boehringer Ingelheim GmbH (Germany) Recent Development
  • 12.12 Bristol-Myers Squibb Company (USA)
    • 12.12.1 Bristol-Myers Squibb Company (USA) Corporation Information
    • 12.12.2 Bristol-Myers Squibb Company (USA) Business Overview
    • 12.12.3 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
    • 12.12.4 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Products Offered
    • 12.12.5 Bristol-Myers Squibb Company (USA) Recent Development
  • 12.13 Allergan, Inc. (USA)
    • 12.13.1 Allergan, Inc. (USA) Corporation Information
    • 12.13.2 Allergan, Inc. (USA) Business Overview
    • 12.13.3 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
    • 12.13.4 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Products Offered
    • 12.13.5 Allergan, Inc. (USA) Recent Development
  • 12.14 Novartis AG (Switzerland)
    • 12.14.1 Novartis AG (Switzerland) Corporation Information
    • 12.14.2 Novartis AG (Switzerland) Business Overview
    • 12.14.3 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
    • 12.14.4 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Products Offered
    • 12.14.5 Novartis AG (Switzerland) Recent Development
  • 12.15 Novo Nordisk A/S (Denmark)
    • 12.15.1 Novo Nordisk A/S (Denmark) Corporation Information
    • 12.15.2 Novo Nordisk A/S (Denmark) Business Overview
    • 12.15.3 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
    • 12.15.4 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Products Offered
    • 12.15.5 Novo Nordisk A/S (Denmark) Recent Development
  • 12.16 Pfizer, Inc. (USA)
    • 12.16.1 Pfizer, Inc. (USA) Corporation Information
    • 12.16.2 Pfizer, Inc. (USA) Business Overview
    • 12.16.3 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
    • 12.16.4 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Products Offered
    • 12.16.5 Pfizer, Inc. (USA) Recent Development
  • 12.17 Sanofi S.A (France)
    • 12.17.1 Sanofi S.A (France) Corporation Information
    • 12.17.2 Sanofi S.A (France) Business Overview
    • 12.17.3 Sanofi S.A (France) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
    • 12.17.4 Sanofi S.A (France) Pediatric Drugs and Vaccines Products Offered
    • 12.17.5 Sanofi S.A (France) Recent Development
  • 12.18 Shionogi Inc. (USA)
    • 12.18.1 Shionogi Inc. (USA) Corporation Information
    • 12.18.2 Shionogi Inc. (USA) Business Overview
    • 12.18.3 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
    • 12.18.4 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Products Offered
    • 12.18.5 Shionogi Inc. (USA) Recent Development
  • 12.19 Takeda
    • 12.19.1 Takeda Corporation Information
    • 12.19.2 Takeda Business Overview
    • 12.19.3 Takeda Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
    • 12.19.4 Takeda Pediatric Drugs and Vaccines Products Offered
    • 12.19.5 Takeda Recent Development

13 Pediatric Drugs and Vaccines Manufacturing Cost Analysis

  • 13.1 Pediatric Drugs and Vaccines Key Raw Materials Analysis
    • 13.1.1 Key Raw Materials
    • 13.1.2 Key Raw Materials Price Trend
    • 13.1.3 Key Suppliers of Raw Materials
  • 13.2 Proportion of Manufacturing Cost Structure
  • 13.3 Manufacturing Process Analysis of Pediatric Drugs and Vaccines
  • 13.4 Pediatric Drugs and Vaccines Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

  • 14.1 Marketing Channel
  • 14.2 Pediatric Drugs and Vaccines Distributors List
  • 14.3 Pediatric Drugs and Vaccines Customers

15 Market Dynamics

  • 15.1 Pediatric Drugs and Vaccines Market Trends
  • 15.2 Pediatric Drugs and Vaccines Drivers
  • 15.3 Pediatric Drugs and Vaccines Market Challenges
  • 15.4 Pediatric Drugs and Vaccines Market Restraints

16 Research Findings and Conclusion

    17 Appendix

    • 17.1 Research Methodology
      • 17.1.1 Methodology/Research Approach
      • 17.1.2 Data Source
    • 17.2 Author List

    The global Pediatric Drugs and Vaccines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pediatric Drugs and Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

    Segment by Type
    Diphtheria
    Influenza
    Hepatitis
    Pneumococcal Diseases
    Meningococcal Diseases
    Mumps
    Others

    Segment by Application
    Newborn
    Infant
    Child

    The Pediatric Drugs and Vaccines market is analysed and market size information is provided by regions (countries). Segment by Application, the Pediatric Drugs and Vaccines market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

    By Company
    Merck & Co., Inc. (USA)
    Abbott Laboratories (USA)
    Amgen, Inc. (USA)
    Eli Lilly and Company (USA)
    F. Hoffmann-La Roche Ltd (Switzerland)
    Genentech, Inc. (USA)
    GlaxoSmithKline plc. (UK)
    Janssen Biologics B.V. (USA)
    Actelion Pharmaceuticals
    AstraZeneca Plc. (UK)
    Boehringer Ingelheim GmbH (Germany)
    Bristol-Myers Squibb Company (USA)
    Allergan, Inc. (USA)
    Novartis AG (Switzerland)
    Novo Nordisk A/S (Denmark)
    Pfizer, Inc. (USA)
    Sanofi S.A (France)
    Shionogi Inc. (USA)
    Takeda

    Buy now